Chaoqun Ma

Mr. Chaoqun Ma

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2025 in International Journal of Qualitative Studies on Health and Well-being
Verified
Journal Article
Open access
LZLewen Zou
Lewen Zou
Chaoqun MaChaoqun Ma
Chaoqun Ma
XLXin Liang
Xin Liang
MLMiaoji Lu
Miaoji Lu
RWRui Wang
Rui Wang
ZXZhuli Xu
Zhuli Xu
As the population ages, the number of elderly patients with chronic diseases increases. It is crucial to focus on the medication experience of elderly patients and their family caregivers during transitions of care (TOC) to improve prognosis and ensure medication safety. However, existing evidence mainly focuses on communication experiences of medication management during this period, which constitutes only part of the overall medication experience. This study aims to systematically review qualitative research exploring the medication experience of elderly patients and caregivers during TOC and provide insights for enhancing their medication experience and ensuring safety during this critical time. We followed ENTREQ and PRISMA to guide this study. Seven electronic databases (CENTRAL, CINAHL, Embase, PsycInfo, PubMed, Scopus, and Web of Science) were systematically searched for studies published up to April 2025, to include qualitative data regarding the medication experiences of elderly patients and their family caregivers during the TOC period. The data were analyzed using thematic synthesis to systematically synthesize the qualitative evidence. In the initial phase, 3,336 studies were screened, with 13 studies ultimately meeting the inclusion criteria: 12 qualitative studies and 1 mixed-methods study. Four main themes emerged: multidimensional experience of medication continuity disruption during TOC, experience of participation in decision-making about medication, experience of communication and information barriers, and experience of multidimensional strategies to improve patient and family caregiver-centered medication. Gaps and fragmentation in the transformation of medication information frequently occurred during the TOC period, leading to a negative medication experience for elderly patients and their caregivers. Healthcare providers should pay close attention to the impact of the care transition period on this group's medication experience, adapting 'patient and family caregiver-centered' diversified adjustment strategies to help them navigate this period safely and smoothly.

21 July 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
Chaoqun MaChaoqun Ma
Chaoqun Ma
YWYao Wu
Yao Wu
JHJiawen He
Jiawen He
JHJiaLian Huang
JiaLian Huang
YLYingying Li
Yingying Li
Objectives: To systematically map postoperative delirium (POD) prediction models in cancer patients, focusing on study design, modeling methods, performance evaluation, and reporting standards. Methods: Following the Arksey and O’Malley framework and PRISMA-ScR guidelines, nine databases were searched from inception to 24 April 2026. Studies developing or validating POD prediction models in cancer patients were included and narratively synthesized. Results: Thirty-two studies conducted in China, South Korea, the United States, the Netherlands, and Japan were included, most of which had a high risk of bias. POD incidence ranged from 6.70% to 46.39%. The Confusion Assessment Method was the most common assessment tool, and logistic regression was the predominant modeling approach. The most frequently identified predictor domains were age, operation/anesthesia time, preoperative nutritional indicators, preoperative inflammatory indicators, and American Society of Anesthesiologists physical status classification. AUC values ranged from 0.690 to 0.973, and C-index values ranged from 0.783 to 0.963. However, 43.75% of studies only evaluated performance in the development dataset, 25.00% conducted external validation, and 43.75% did not assess clinical utility. Although 87.50% of studies visually presented models, interpretability analyses for machine-learning models were insufficient. Conclusions: Existing POD prediction models for cancer patients show promising discrimination, but their readiness for routine clinical use remains limited by insufficient external validation, inconsistent clinical utility assessment, and incomplete model transparency. These models should currently be regarded as risk stratification tools rather than definitive clinical decision aids. Future studies should prioritize standardized reporting, multicenter external validation, model updating, and decision-curve analysis to support safe clinical translation.